BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6179569)

  • 1. Monoamine metabolite concentrations in the cerebrospinal fluid of normal and narcoleptic dogs.
    Faull KF; Barchas JD; Foutz AS; Dement WC; Holman RB
    Brain Res; 1982 Jun; 242(1):137-43. PubMed ID: 6179569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
    Faull KF; Thiemann S; King RJ; Guilleminault C
    Sleep; 1986; 9(1 Pt 2):246-9. PubMed ID: 2422716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The concentrations of amine metabolites in cerebrospinal fluid from normal and narcoleptic dogs [proceedings].
    Barchas JD; Dement WC; Faull K; Foutz AS; Holman RB
    J Physiol; 1979 Nov; 296():94P-95P. PubMed ID: 93641
    [No Abstract]   [Full Text] [Related]  

  • 4. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.
    Faull KF; Guilleminault C; Berger PA; Barchas JD
    Ann Neurol; 1983 Mar; 13(3):258-63. PubMed ID: 6189447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenic amine metabolism in Tourette syndrome.
    Butler IJ; Koslow SH; Seifert WE; Caprioli RM; Singer HS
    Ann Neurol; 1979 Jul; 6(1):37-9. PubMed ID: 292354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia.
    Roy A; Pickar D; Linnoila M; Doran AR; Ninan P; Paul SM
    Psychiatry Res; 1985 Aug; 15(4):281-92. PubMed ID: 2415996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3,4-Dihydroxyphenylethylamine and 5-hydroxytryptamine metabolism in the rat: acidic metabolites in cisternal cerebrospinal fluid before and after giving probenecid.
    Curzon G; Hutson PH; Kantamaneni BD; Sahakian BJ; Sarna GS
    J Neurochem; 1985 Aug; 45(2):508-13. PubMed ID: 2409231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptophan and biogenic amine metabolites in post-mortem human cisternal fluid: effects of post-mortem interval and agonal time.
    Kärkelä J; Scheinin M
    J Neurol Sci; 1992 Feb; 107(2):239-45. PubMed ID: 1373441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Methoxy-4-hydroxy-phenylglycol sulfate (MOPEG-SO4) in ventricular and cisternal cerebrospinal fluid of dogs.
    Bareggi SR; Stabenau JR; Shaskan EG; Becker RE; Roberts M
    J Neurosci Res; 1975; 1(5-6):471-4. PubMed ID: 1226000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions.
    Coplan JD; Trost RC; Owens MJ; Cooper TB; Gorman JM; Nemeroff CB; Rosenblum LA
    Arch Gen Psychiatry; 1998 May; 55(5):473-7. PubMed ID: 9596051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality and cerebrospinal fluid monoamine metabolites in alcoholics and controls.
    Limson R; Goldman D; Roy A; Lamparski D; Ravitz B; Adinoff B; Linnoila M
    Arch Gen Psychiatry; 1991 May; 48(5):437-41. PubMed ID: 1708656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
    Prell GD; Green JP; Elkashef AM; Khandelwal JK; Linnoila M; Wyatt RJ; Lawson WB; Jaeger AC; Kaufmann CA; Kirch DG
    Schizophr Res; 1996 May; 19(2-3):171-6. PubMed ID: 8789915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free and conjugated amines in human lumbar cerebrospinal fluid.
    Tyce GM; Rorie DK; Byer DE; Danielson DR
    J Neurochem; 1985 Jan; 44(1):322-4. PubMed ID: 2578061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.